238 related articles for article (PubMed ID: 29995873)
1. RNA-seq analysis identifies different transcriptomic types and developmental trajectories of primary melanomas.
Kunz M; Löffler-Wirth H; Dannemann M; Willscher E; Doose G; Kelso J; Kottek T; Nickel B; Hopp L; Landsberg J; Hoffmann S; Tüting T; Zigrino P; Mauch C; Utikal J; Ziemer M; Schulze HJ; Hölzel M; Roesch A; Kneitz S; Meierjohann S; Bosserhoff A; Binder H; Schartl M
Oncogene; 2018 Nov; 37(47):6136-6151. PubMed ID: 29995873
[TBL] [Abstract][Full Text] [Related]
2. BRAF and NRAS mutations in melanoma and melanocytic nevi.
Poynter JN; Elder JT; Fullen DR; Nair RP; Soengas MS; Johnson TM; Redman B; Thomas NE; Gruber SB
Melanoma Res; 2006 Aug; 16(4):267-73. PubMed ID: 16845322
[TBL] [Abstract][Full Text] [Related]
3. A Transcriptome-Wide Isoform Landscape of Melanocytic Nevi and Primary Melanomas Identifies Gene Isoforms Associated with Malignancy.
Hakobyan S; Loeffler-Wirth H; Arakelyan A; Binder H; Kunz M
Int J Mol Sci; 2021 Jul; 22(13):. PubMed ID: 34281234
[TBL] [Abstract][Full Text] [Related]
4. Molecular classification of melanomas and nevi using gene expression microarray signatures and formalin-fixed and paraffin-embedded tissue.
Koh SS; Opel ML; Wei JP; Yau K; Shah R; Gorre ME; Whitman E; Shitabata PK; Tao Y; Cochran AJ; Abrishami P; Binder SW
Mod Pathol; 2009 Apr; 22(4):538-46. PubMed ID: 19270649
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Distinction of Malignant Melanoma and Benign Nevi by a Gene Expression Signature and Correlation to Clinical Outcomes.
Ko JS; Matharoo-Ball B; Billings SD; Thomson BJ; Tang JY; Sarin KY; Cai E; Kim J; Rock C; Kimbrell HZ; Flake DD; Warf MB; Nelson J; Davis T; Miller C; Rushton K; Hartman AR; Wenstrup RJ; Clarke LE
Cancer Epidemiol Biomarkers Prev; 2017 Jul; 26(7):1107-1113. PubMed ID: 28377414
[No Abstract] [Full Text] [Related]
6. Zebrafish MITF-Low Melanoma Subtype Models Reveal Transcriptional Subclusters and MITF-Independent Residual Disease.
Travnickova J; Wojciechowska S; Khamseh A; Gautier P; Brown DV; Lefevre T; Brombin A; Ewing A; Capper A; Spitzer M; Dilshat R; Semple CA; Mathers ME; Lister JA; Steingrimsson E; Voet T; Ponting CP; Patton EE
Cancer Res; 2019 Nov; 79(22):5769-5784. PubMed ID: 31582381
[TBL] [Abstract][Full Text] [Related]
7. [Immunohistochemical analysis of ras gene expression in human melanomas and melanocytic nevi].
Yasuda H
Hokkaido Igaku Zasshi; 1989 May; 64(3):243-53. PubMed ID: 2670726
[TBL] [Abstract][Full Text] [Related]
8. In-depth genomic data analyses revealed complex transcriptional and epigenetic dysregulations of BRAFV600E in melanoma.
Guo X; Xu Y; Zhao Z
Mol Cancer; 2015 Mar; 14():60. PubMed ID: 25890285
[TBL] [Abstract][Full Text] [Related]
9. The gene expression signatures of melanoma progression.
Haqq C; Nosrati M; Sudilovsky D; Crothers J; Khodabakhsh D; Pulliam BL; Federman S; Miller JR; Allen RE; Singer MI; Leong SP; Ljung BM; Sagebiel RW; Kashani-Sabet M
Proc Natl Acad Sci U S A; 2005 Apr; 102(17):6092-7. PubMed ID: 15833814
[TBL] [Abstract][Full Text] [Related]
10. Mapping heterogeneity in patient-derived melanoma cultures by single-cell RNA-seq.
Gerber T; Willscher E; Loeffler-Wirth H; Hopp L; Schadendorf D; Schartl M; Anderegg U; Camp G; Treutlein B; Binder H; Kunz M
Oncotarget; 2017 Jan; 8(1):846-862. PubMed ID: 27903987
[TBL] [Abstract][Full Text] [Related]
11. Development of a novel noninvasive adhesive patch test for the evaluation of pigmented lesions of the skin.
Gerami P; Alsobrook JP; Palmer TJ; Robin HS
J Am Acad Dermatol; 2014 Aug; 71(2):237-44. PubMed ID: 24906614
[TBL] [Abstract][Full Text] [Related]
12. Frequent alterations of Ras signaling pathway genes in sporadic malignant melanomas.
Reifenberger J; Knobbe CB; Sterzinger AA; Blaschke B; Schulte KW; Ruzicka T; Reifenberger G
Int J Cancer; 2004 Apr; 109(3):377-84. PubMed ID: 14961576
[TBL] [Abstract][Full Text] [Related]
13. Gene expression signature as an ancillary method in the diagnosis of desmoplastic melanoma.
Clarke LE; Pimentel JD; Zalaznick H; Wang L; Busam KJ
Hum Pathol; 2017 Dec; 70():113-120. PubMed ID: 29079183
[TBL] [Abstract][Full Text] [Related]
14. Mutations of the BRAF gene in benign and malignant melanocytic lesions.
Yazdi AS; Palmedo G; Flaig MJ; Puchta U; Reckwerth A; Rütten A; Mentzel T; Hügel H; Hantschke M; Schmid-Wendtner MH; Kutzner H; Sander CA
J Invest Dermatol; 2003 Nov; 121(5):1160-2. PubMed ID: 14708620
[TBL] [Abstract][Full Text] [Related]
15. The Genetic Evolution of Melanoma from Precursor Lesions.
Shain AH; Yeh I; Kovalyshyn I; Sriharan A; Talevich E; Gagnon A; Dummer R; North J; Pincus L; Ruben B; Rickaby W; D'Arrigo C; Robson A; Bastian BC
N Engl J Med; 2015 Nov; 373(20):1926-36. PubMed ID: 26559571
[TBL] [Abstract][Full Text] [Related]
16. Transcriptome sequencing of melanocytic nevi and melanomas from Grm1 transgenic mice to determine melanoma driver mutations.
de Jel MM; Engelmann JC; Kunz M; Schiffner S; Kuphal S; Bosserhoff AK
Pigment Cell Melanoma Res; 2014 Jul; 27(4):678-80. PubMed ID: 24661573
[No Abstract] [Full Text] [Related]
17. Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions.
Zembowicz A; Knoepp SM; Bei T; Stergiopoulos S; Eng C; Mihm MC; Stratakis CA
Am J Surg Pathol; 2007 Nov; 31(11):1764-75. PubMed ID: 18059235
[TBL] [Abstract][Full Text] [Related]
18. Phenotypic characterization of nevus and tumor patterns in MITF E318K mutation carrier melanoma patients.
Sturm RA; Fox C; McClenahan P; Jagirdar K; Ibarrola-Villava M; Banan P; Abbott NC; Ribas G; Gabrielli B; Duffy DL; Peter Soyer H
J Invest Dermatol; 2014 Jan; 134(1):141-149. PubMed ID: 23774529
[TBL] [Abstract][Full Text] [Related]
19. Molecular pathogenesis of malignant melanoma: a different perspective from the studies of melanocytic nevus and acral melanoma.
Takata M; Murata H; Saida T
Pigment Cell Melanoma Res; 2010 Feb; 23(1):64-71. PubMed ID: 19788535
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of MITF p.E318K in Patients With Melanoma Independent of the Presence of CDKN2A Causative Mutations.
Potrony M; Puig-Butille JA; Aguilera P; Badenas C; Tell-Marti G; Carrera C; Javier Del Pozo L; Conejo-Mir J; Malvehy J; Puig S
JAMA Dermatol; 2016 Apr; 152(4):405-12. PubMed ID: 26650189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
